UMIN ID: UMIN000000729
Registered date:10/06/2007
Comprison of the renoprotecrive and the antihypertensive effects of Olmesartan vs Losartan + low dose diuretics in normoalbuminuric diabetic patients
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | diabetes |
Date of first enrollment | 2007/04/01 |
Target sample size | 30 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Olmesartan (20mg) Losartan (50mg) + hydrochlorothiazide (12.5mg) or trichlorothiazide (1mg) |
Outcome(s)
Primary Outcome | 1. changes in urinary IgG, transferrin and ceruloplasmin excretions 2. blood pressure lowering effects. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 80years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1. Past history of microalbuminuria, overt proteinuria or any kidney diseases 2. Pregnancy 3. Severe liver dysfunction 4. Cancer 5. Poor glycemic control (HbA1c > 10%) 6. Other reasons for exclusion |
Related Information
Primary Sponsor | Akita Olmesartan renoprotection study group |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Self funding |
Secondary ID(s) |
Contact
public contact | |
Name | Takuma Narita |
Address | Hondo 1-1-1, Akita, Japan Japan |
Telephone | |
Affiliation | Akita University School of Medicine Endocrinology, diabetes and geriatric medicine |
scientific contact | |
Name | Takuma Narita |
Address | Hondo 1-1-1, Akita, Japan Japan |
Telephone | 018-884-6040 |
Affiliation | Akita University School of Medicine Endocrinology, diabetes and geriatric medicine |